PUR-001
- Generic Name
- PUR-001
Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-02-10
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Purinomia Biotech, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT05234853
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath